James Gray
Family Medicine · Fayetteville, TNNPI 1497869259
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 403 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,000 and has fallen 99.0% since, to $21 in 2025.
Across 403 payments — averaging $14.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$834
- Amgen$742
- AstraZeneca$361
- Boehringer Ingelheim$341
- AbbVie$337
- Merck$336
- plus $3K from 29 others
Across 21 payments — averaging $850.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Esperion Therapeutics, Inc.$18K
What the payments were for
- Food & beverage$5,693100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 74 | $834 |
| Amgen | 45 | $742 |
| AstraZeneca | 26 | $361 |
| Boehringer Ingelheim | 27 | $341 |
| AbbVie(2 entities) | 22 | $337 |
| Merck | 26 | $336 |
| Johnson & Johnson | 23 | $314 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $303 |
| Novartis | 18 | $241 |
| Biohaven Pharmaceuticals, Inc. | 14 | $236 |
| Sanofi-aventis U.S. LLC | 16 | $231 |
| Lilly USA, LLC | 18 | $222 |
| Pfizer | 14 | $208 |
| E.r. Squibb & Sons, L.L.C. | 9 | $142 |
| Ironwood Pharmaceuticals, Inc | 9 | $113 |
| Avanir Pharmaceuticals, Inc. | 5 | $88 |
| Eisai Inc. | 5 | $86 |
| Sanofi Pasteur Inc. | 4 | $60 |
| Mylan Specialty L.p. | 4 | $59 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $58 |
| Astellas Pharma US Inc | 3 | $50 |
| Kyowa Kirin, Inc. | 3 | $41 |
| GSK | 3 | $40 |
| Sunovion Pharmaceuticals Inc. | 3 | $36 |
| Amarin Pharma, Inc. | 2 | $34 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Bayer | 1 | $23 |
| Adamas Pharmaceuticals, Inc. | 1 | $20 |
| Abbott | 1 | $19 |
| Lexicon Pharmaceuticals, Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $16 |
| Almatica Pharma LLC | 1 | $15 |
| Scilex Pharmaceuticals Inc. | 1 | $13 |
| Otsuka America Pharmaceutical, Inc. | 1 | $12 |
How this compares
$5,702 in reported general payments places this provider in the 85th percentile of 2,087 family medicine providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Propranolol Hcl | 13 | $285 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Fayetteville
- Kevin DennisFranklin$354K
- Charolette JacksonBartlett$162K
- Keren HolmesNashville$58K
- Kabir Harricharan SinghNewport$49K
- Khaisha GistAntioch$49K
- Jerry PunchKnoxville$45K
- Christopher HollowayAntioch$41K
- Curtis JantziKingsport$39K
- Ellen ClelandChattanooga$38K
- Meredith SchweitzerAntioch$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.